SG
AGN.PRA

Societe Generale’s Allergan plc AGN.PRA Stock Holding History

Societe Generale’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$83.1M Buy
+99,699
New +$83.3M 0.59% 19

Other funds holding AGN.PRA

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Societe Generale's AGN.PRA Position: Q2 2016 in Review

Societe Generale opened a new position in Allergan plc (AGN.PRA) in Q2 2016: 99,699 shares worth $83.1M. The stake represents 0.59% of the portfolio and ranks #19 among its holdings.

108 funds tracked by Wall St. Rank hold AGN.PRA as of Q2 2016.

  • Societe Generale held 99,699 shares of Allergan plc worth $83.1M as of Q2 2016.
  • Allergan plc was a new Societe Generale position in Q2 2016.
  • Allergan plc made up 0.59% of Societe Generale's portfolio in Q2 2016, its #19 holding.
  • 108 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.